Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00380159
Status:
COMPLETED
Last Update Posted:
2023-08-14
First Post:
2006-09-21
Brief Title:
Open-Label 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy ART for Participants Who Have Completed Study ACH443-014A
Sponsor:
Organization:
Alexion Pharmaceuticals Inc